معرفی
Dr Harry Bulstrode is a Principal Investigator at the Cambridge Stem Cell Institute, University of Cambridge. His research bridges neural stem cell biology, brain tumor mechanisms, and neurodegenerative disease therapy.
Education:
- Doctor of Medicine, University of Cambridge (BA 2003), University of Oxford (BMBCh 2006)
- PhD in Neural Stem Cell Biology, University of Edinburgh (2012-2015)
Research Focus:
Harry’s work explores how neural stem cells interact with their brain microenvironment in both cancer and regenerative medicine. His lab investigates:
- Zika virus targeting of stem cells and its implications for glioma therapy
- Transcriptional programs (FOXG1, SOX2) driving glioblastoma stem cell identity
- Immune modulation strategies to disrupt oncogenic stem cell processes
- Optimized cell delivery methods for treating Parkinson’s Disease
- Computational models of spatiotemporal tumor heterogeneity
- Single-cell sequencing to dissect glial signatures in health and disease
Publications highlight his work in oncolytic virotherapy, stem cell dynamics, and myeloid cell interactions with neural progenitors.
Awards:
- Wellcome Clinician Career Development Fellowship (current)
Lab Members:
Sahil Dayal (MPhil Student), George Solomou (PhD Programme for Health Professionals), Athena Stamper (PhD Student), Xin Tang (PhD Student), An Truong (Research Assistant/Associate), Daniel Yamamoto (Research Assistant), Grace Wilson (PhD Student), Adam Young (Clinical Lecturer).
